Controlling parasympathetic regulation of heart rate: A gatekeeper role for RGS proteins in the sinoatrial node

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Mighiu, Alexandra S ^a   Heximer, Scott P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bradyarrhythmia; GIRK channels; Parasympathetic signaling; RGS protein; Sinoatrial node

Indexed keywords

EID: 84866425645     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00204     Document Type: Review

References (69)

1. Aistrup, G. L., Cokic, I., Ng, J., Gordon, D., Koduri, H., Browne, S., Arapi, D., Segon, Y., Goldstein, J., Angulo, A., Wasserstrom, J. A., Gold-berger, J. J., Kadish, A. H., and Arora, R. (2011). Targeted nonviral gene-based inhibition of Galpha(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation. Heart Rhythm 8, 1722-1729.
2. Aistrup, G. L., Villuendas, R., Ng, J., Gilchrist, A., Lynch, T. W., Gordon, D., Cokic, I., Mottl, S., Zhou, R., Dean, D. A., Wasserstrom, J. A., Goldberger, J. J., Kadish, A. H., and Arora, R. (2009). Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation. Cardiovasc. Res. 83, 481-492.
3. Benditt, D. G., Sakaguchi, S., Goldstein, M. A., Lurie, K. G., Gornick, C. C., andAdler,S.W. (1995). "Sinus node dysfunction: pathophysiology, clinical features, evaluation, and treatment," in Cardiac Electrophysiology: From Cell to Bedside, 2nd Edn, eds D. P. Zipes and J. Jalife (Philadelphia, PA: WB Saunders Company), 1215-1247.
4. Benson, D. W., Wang, D. W., Dyment, M., Knilans, T. K., Fish, F. A., Strieper, M. J., Rhodes, T. H., and George, A. L. Jr. (2003). Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112, 1019-1028.
5. Berman, D. M., Wilkie, T. M., and Gilman, A. G. (1996). GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445-452.
6. Bezzina, C., Veldkamp, M. W., Van Den Berg, M. P., Postma, A. V., Rook, M. B., Viersma, J. W., van Langen, I. M., Tan-Sindhunata, G., Bink-Boelkens, M. T., Van Der Hout, A. H., Mannens, M. M., and Wilde, A. A. (1999). A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 85,1206-1213.
7. Bolter, C. P., and Wilson, S. J. (1999). Influence of right atrial pressure on the cardiac pacemaker response to vagal stimulation. Am. J. Physiol. 276,R1112-R1117.
8. Chou, C. C., Nguyen, B. L., Tan, A. Y., Chang, P. C., Lee, H. L., Lin, F. C., Yeh, S. J., Fishbein, M. C., Lin, S. F., Wu, D., Wen, M. S., and Chen, P. S. (2008). Intracellular calcium dynamics and acetylcholine-induced triggered activity in the pulmonary veins of dogs with pacing-induced heart failure. Heart Rhythm 5,1170-1177.
9. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., Deshpande, S. N., Thelma, B. K., Fer-rell, R. E., Middleton, E A., Devlin, B., Levitt, P., Lewis, D. A., and Nim-gaonkar, V. L. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11,1373-1380.
10. Cifelli, C., Rose, R. A., Zhang, H., Voigtlaender-Bolz, J., Bolz, S. S., Backx, P. H., and Heximer, S. P. (2008). RGS4 regulates parasympa-thetic signaling and heart rate control in the sinoatrial node. Circ. Res. 103, 527-535.
11. Clapham,D.E.,andNeer,E.J. (1997). G protein beta gamma subunits. Annu. Rev. Pharmacol. Toxicol. 37,167-203.
12. Coumel, P. (1996). Autonomic influences in atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 7, 999-1007.
13. DiFrancesco, D. (1993). Pacemaker mechanisms in cardiac tissue. Annu. Rev. Physiol. 55,455-472.
14. DiFrancesco, D. (2006). Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol. Res. 53, 399-406.
15. Dobrev, D., Friedrich, A., Voigt, N., Jost, N., Wettwer, E., Christ, T., Knaut, M., and Ravens, U. (2005). The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 112, 3697-3706.
16. Dobrev, D., Wettwer, E., Himmel, H. M., Kortner, A., Kuhlisch, E., Schuler, S., Siffert, W., and Ravens, U. (2000). G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. Circulation 102, 692-697.
17. Dobrzynski, H., Boyett, M. R., and Anderson, R. H. (2007). New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115, 1921-1932.
18. Doupnik, C. A., Davidson, N., Lester, H. A., and Kofuji, P. (1997). RGS proteins reconstitute the rapid gating kinetics of gbetagamma- activated inwardly rectifying K+ channels. Proc. Natl Acad. Sci. U.S.A. 94, 10461-10466.
19. Doupnik, C. A., Jaen, C., and Zhang, Q. (2004). Measuring the modu-latory effects of RGS proteins on GIRK channels. Meth. Enzymol. 389, 131-154.
20. Doupnik, C. A., Xu, T., and Shinaman, J. M. (2001). Profile of RGS expression in single rat atrial myocytes. Biochim. Biophys. Acta 1522,97-107.
21. Druey, K. M., Blumer, K. J., Kang, V. H., and Kehrl, J. H. (1996). Inhibition of G-protein-mediated MAP kinase activation by anewmammalian gene family. Nature 379, 742-746.
22. Fischmeister, R., Castro, L. R., Bi-Gerges, A., Rochais, F., Jurevicius, J., Leroy, J., and Vandecasteele, G. (2006). Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodi-esterases. Circ. Res. 99, 816-828.
23. Fu, Y., Huang, X., Piao, L., Lopatin, A. N., and Neubig, R. R. (2007). Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. Am. J. Physiol. Heart Circ. Physiol. 292, H2532-H2539.
24. Fu, Y., Huang, X., Zhong, H., Mortensen, R. M., D'Alecy, L. G., and Neubig, R. R. (2006). Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. Circ. Res. 98, 659-666.
25. Groenewegen, W. A., Firouzi, M., Bezzina, C. R., Vliex, S., Van Langen, I. M., Sandkuijl, L., Smits, J. P., Huls-beek, M., Rook, M. B., Jongsma, H. J., and Wilde, A. A. (2003). A cardiac sodium channel mutation cosegre-gates with a rare connexin40 genotype in familial atrial standstill. Circ. Res. 92, 14-22.
26. Hamm, H. E. (1998). The many faces of G protein signaling. J. Biol. Chem. 273, 669-672.
27. Han, S., Wilson, S. J., and Bolter, C. P. (2010). Tertiapin-Q removes a mechanosensitive component of muscarinic control of the sinoatrial pacemaker in the rat. Clin. Exp. Pharmacol. Physiol. 37, 900-904.
28. Hashimoto, N., Yamashita, T., and Tsu-ruzoe, N. (2006). Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective a trial effective refractory period prolongation. Pharmacol Res. 54, 136-141.
29. Hepler, J. R. (1999). Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci. 20, 376-382.
30. Herweg, B., Dalal, P., Nagy, B., and Schweitzer, P. (1998). Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am. J. Cardiol. 82, 869-874.
31. Irisawa, H., Brown, H. F., and Giles, W (1993). Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 73, 197-227.
32. Ishii, M.,Inanobe,A., Fujita, S., Makino, Y.,Hosoya,Y.,andKurachi,Y. (2001). Ca(2+) elevation evoked by membrane depolarization regulates G protein cycle via RGS proteins in the heart. Circ. Res. 89, 1045-1050.
33. Ishii, M., Inanobe, A., and Kurachi, Y. (2002). PIP3 inhibition of RGS protein and its reversal by Ca2+/calmodulin mediate voltage-dependent control of the G protein cycle in a cardiac K+ channel. Proc. Natl. Acad. Sci. U.S.A. 99, 4325-4330.
34. Jaen, C., and Doupnik, C. A. (2006). RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling. J. Biol. Chem. 281,34549-34560.
35. Kardestuncer, T.,Wu, H.,Lim, A. L., and Neer, E. J. (1998). Cardiac myocytes express mRNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria. FEBS Lett. 438,285-288.
36. Kimple, A. J., Bosch, D. E., Giguere, P. M., and Siderovski, D. P. (2011). Regulators of G-protein signaling and their Galpha substrates: promises and challenges in their use as drug discovery targets. Pharmacol. Rev. 63, 728-749.
37. Kovoor, P., Wickman, K., Maguire, C. T., Pu, W., Gehrmann, J., Berul, C. I., and Clapham, D. E. (2001). Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J. Am. Coll. Cardiol. 37, 2136-2143.
38. Kubo,Y.,Reuveny,E.,Slesinger,P.A.,Jan, Y. N., and Jan, L. Y. (1993). Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 364, 802-806.
39. Mangrum, J. M., and DiMarco, J. P. (2000). The evaluation and management of bradycardia. N Engl. J. Med. 342,703-709.
40. Milanesi, R., Baruscotti, M., Gnecchi-Ruscone, T., and Difrancesco, D. (2006). Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl. J.Med. 354, 151-157.
41. Mittmann, C., Chung, C. H., Hoppner, G., Michalek, C., Nose, M., Schuler, C., Schuh, A., Eschenhagen, T., Weil, J., Pieske, B., Hirt, S., and Wieland, T. (2002). Expression of ten RGS proteins in human myocardium: functional characterization of an upreg-ulation of RGS4 in heart failure. Cardiovasc. Res. 55, 778-786.
42. Mohler, P. J., and Bennett, V. (2005). Ankyrin-based cardiac arrhythmias: anew class of channelopathies due to loss of cellular targeting. Curr. Opin. Cardiol. 20, 189-193.
43. Morris, D. W., Rodgers, A., McGhee, K. A., Schwaiger, S., Scully, P., Quinn, J., Meagher, D., Waddington, J. L., Gill, M., and Corvin, A. P. (2004). Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 125B,50-53.
44. Pacey, L. K., Heximer, S. P., and Hampson, D. R. (2009). Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol Pharmacol. 76, 18-24.
45. Popov, S. G., Krishna, U. M., Falck, J. R., and Wilkie, T. M. (2000). Ca2+/Calmodulin reverses phosphatidylinositol 3,4, 5-trisphosphate-dependent inhibition of regulators of G protein-signaling GTPase-activating protein activity. J. Biol. Chem. 275, 18962-18968.
46. Posokhova, E., Wydeven, N., Allen, K. L., Wickman, K., and Martemyanov, K. A. (2010). RGS6/Gss5 complex accelerates IKACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Circ. Res. 107, 1350-1354.
47. Rogers, J. H., Tamirisa, P., Kovacs, A., Weinheimer, C., Courtois, M., Blumer, K. J., Kelly, D. P., and Muslin, A. J. (1999). RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.J. Clin. Invest. 104, 567-576.
48. Rogers, J. H., Tsirka, A., Kovacs, A., Blumer, K. J., Dorn, G. W., and Muslin, A. J. (2001). RGS4 reduces contractile dysfunction and hyper-trophic gene induction in Galpha q overexpressing mice. J. Mol. Cell. Cardiol. 33,209-218.
49. Ross, E. M., and Wilkie, T. M. (2000). GTPase-activating proteins for het-erotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69, 795-827.
50. Ruiz de Azua, I., Scarselli, M., Rose-mond, E., Gautam, D., Jou, W., Gavrilova, O., Ebert, P. J., Levitt, P., and Wess, J. (2010). RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 107, 7999-8004.
51. Schreieck, J., Dostal, S., Von Beckerath, N., Wacker, A., Flory, M., Weyer-brock, S., Koch, W., Schomig, A., and Schmitt, C. (2004). C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am. HeartJ. 148, 545-550.
52. Schuessler, R. B., Grayson, T. M., Bromberg, B. I., Cox, J. L., and Boineau, J.P. (1992). Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium. Circ. Res. 71, 1254-1267.
53. Schulze-Bahr, E., Neu, A., Friederich, P., Kaupp, U. B., Breithardt, G., Pongs, O., and Isbrandt, D. (2003). Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 111, 1537-1545.
54. Sjogren, B., Blazer, L. L., and Neubig, R. R. (2010). Regulators of G protein signaling proteins as targets for drug discovery. Prog. Mol. Biol. Transl. Sci. 91,81-119.
55. Sjogren, B., and Neubig, R. R. (2010). Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling. Mol. Pharmacol. 78,550-557.
56. Smits, J. P., Koopmann, T. T., Wilders, R., Veldkamp, M. W., Opthof, T., Bhuiyan, Z. A., Mannens, M. M., Balser, J. R., Tan, H. L., Bezzina, C. R., and Wilde, A. A. (2005). A mutation in the human cardiac sodium channel (E1 6 1K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J. Mol. Cell. Cardiol. 38, 969-981.
57. Tamirisa, P., Blumer, K. J., and Muslin, A. J. (1999). RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99, 441-447.
58. Tokudome, T., Kishimoto, I., Horio, T., Arai, Y., Schwenke, D. O., Hino, J., Okano, I., Kawano, Y., Kohno, M., Miyazato, M., Nakao, K., and Kangawa, K. (2008). Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic pep-tides in the heart. Circulation 117, 2329-2339.
59. Ueda, K., Nakamura, K., Hayashi, T., Inagaki, N., Takahashi, M., Arimura, T., Morita, H., Higashiuesato, Y., Hirano, Y., Yasunami, M., Takishita, S.,Yamashina,A., Ohe, T., Sunamori, M., Hiraoka, M., and Kimura, A. (2004). Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J. Biol. Chem. 279,27194-27198.
60. Veldkamp, M. W., Wilders, R., Baartscheer, A., Zegers, J. G., Bezzina, C. R., and Wilde, A. A. (2003). Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ. Res. 92, 976-983.
61. Voigt, N., Maguy, A., Yeh, Y H., Qi, X., Ravens, U., Dobrev, D., and Nattel, S. (2008). Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc. Res. 77, 35-43.
62. Wakimoto, H., Maguire, C. T., Kovoor, P., Hammer, P. E., Gehrmann, J., Triedman, J. K., and Berul, C. I. (2001). Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc. Res. 50, 463-473.
63. Watson, N., Linder, M. E., Druey, K. M., Kehrl, J. H., and Blumer, K. J. (1996). RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383, 172-175.
64. Xie, Y., Wolff, D. W., Wei, T., Wang, B., Deng, C., Kirui, J. K., Jiang, H., Qin, J., Abel, P. W., and Tu, Y. (2009). Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res. 69, 5743-5751.
65. Yang, J., Huang, J., Maity, B., Gao, Z., Lorca, R. A., Gudmundsson, H., Li, J., Stewart, A., Swaminathan, P. D., Ibeawuchi, S. R., Shepherd, A., Chen, C. K., Kutschke, W., Mohler, P. J., Mohapatra, D. P., Anderson, M. E., and Fisher, R. A. (2010). RGS6, a modulator of parasympa-thetic activation in heart. Circ. Res. 107, 1345-1349.
66. Zhang, H.,Gu,S.,Al-Sabeq,B., Wang, S., He, J., Tam, A., Cifelli, C., Mathalone, N., Tirgari, S., Boyd, S., and Heximer, S. P. (2012). Origin-specific epi-genetic program correlates with vascular bed-specific differences in Rgs5 expression. FASEB J. 26, 181-191.
67. Zhang, Q., Dickson, A., and Doupnik, C. A. (2004). Gbetagamma-activated inwardly rectifying K(+) (GIRK) channel activation kinetics via Galphai and Galphao-coupled receptors are determined by Galpha-specific interdomain interactions that affect GDP release rates. J. Biol. Chem. 279,29787-29796.
68. Zhang, Q., Pacheco, M. A., and Doup-nik, C. A. (2002). Gating properties of GIRK channels activated by Galpha(o)- and Galpha(i)-coupled muscarinic m2 receptors in Xeno-pus oocytes: the role of receptor precoupling in RGS modulation. J. Physiol. (Lond.) 545, 355-373.
69. Zhang, S., Watson, N., Zahner, J., Rottman, J. N., Blumer, K. J., and Muslin, A. J. (1998). RGS3 and RGS4 are GTPase activating proteins in the heart. J. AM Cell. Cardiol. 30, 269-276.